This may reflect a need for sustained delivery and transport of BDNF into the CNS parenchyma, as either stem cell-mediated delivery [21], [37], or systemic delivery of BDNF conjugated to a BBB transferrin receptor antibody [20] reduced stroke injury. This evidence concerns the gene TFRC and Stroke.